Abid Ansari

Abid Ansari serves as the Chief Financial Officer at General Oncology since December 2024, while also functioning as a Strategic Financial Advisor for Ansari Consulting LLC since June 2020, focusing on finance, accounting, fundraising, marketing, and operations. Previously, Ansari held the CFO position at Artios Pharma Ltd, leading a successful $153 million Series C financing and transitioning the company to public status with SOX404 compliance. As CFO at Precision BioSciences, Inc., Ansari led a notable $146 million IPO, representing the company at key healthcare conferences. With substantial experience at GSK, Ansari contributed to multiple significant deals in business development and led a global team for R&D investment analytics. Ansari holds a B.S. in Chemical Engineering and an MBA in Finance and Operations Management from Purdue University.